true, among the many unanswered questions, there is also this: why has Moscato not remedied this cause that has dragged on since 2017, by diluting the capital? when it traveled above $ 2, with a couple of million shares it solved the matter.
The quantity and severity of Moscato's errors goes beyond incompetence.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links